Will ART rollout in Africa drive an epidemic of drug resistant HIV?
- 12 June 2006
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (9) , 1354-1356
- https://doi.org/10.1097/01.aids.0000232257.97027.80
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Sensitive Drug‐Resistance Assays Reveal Long‐Term Persistence of HIV‐1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single‐Dose NVP: HIVNET 012The Journal of Infectious Diseases, 2005
- The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical modelsAIDS, 2005
- Long-Term Persistence of Primary Genotypic Resistance After HIV-1 SeroconversionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected menAIDS, 2004
- Predicting the Impact of Antiretrovirals in Resource-Poor Settings: Preventing HIV Infections whilst Controlling Drug ResistanceCurrent Drug Targets - Infectious Disorders, 2003
- Reversibility of HIV Drug ResistanceScience, 2000
- A Tale of Two Futures: HIV and Antiretroviral Therapy in San FranciscoScience, 2000